Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently approved OCREVUS IV 600 ...

When it comes to the early detection of Alzheimer’s disease, a new study suggests that the nose knows. Mass General Brigham neurology researchers have created a smell test that shows promise as a tool ...

A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...

This investigational treatment was generally well tolerated with no serious adverse events; fewer adverse events related to non-motor symptoms were reported in the solengepras arm Pivotal Phase 3 ...

Many woman are blindsided by menopause’s mental health impacts, experts warn, and suffer in silence for years with symptoms ...

Bruce Willis’ family has revealed that his early symptoms of frontotemporal dementia were initially dismissed by doctors, who ...

A Cadillac woman who last year was diagnosed with multiple sclerosis is hoping to raise awareness about the disease as a ...

MS is a complex, unpredictable disease that has taught me the value of perseverance—not only for myself but also for the ...

The "gold standard" for staging Alzheimer’s disease is positron emission tomography (PET) brain scans for amyloid plaques and ...

New findings reveal Black Americans face higher multiple sclerosis, ms rates and mortality while being systematically ...

A new study from researchers in France has found that taking high doses of vitamin D every two weeks may help reduce disease ...

McDonald Criteria revisions around 30% of patients with atypical clinical symptoms or radiological-only presentation meet MS ...